首页> The Journal of clinical investigation> Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients.

导出 OA

翻译打印收藏纠错

第一作者： Ramon,Staeger

第一单位： Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.;Medical Faculty, University of Zurich, Zurich, Switzerland.

作者： Ramon,Staeger ^[1] ; Aizhan,Tastanova ^[1] ; Adhideb,Ghosh ^[2] ; Nicola,Winkelbeiner ^[3] ; Prachi,Shukla ^[1] ; Isabel,Kolm ^[1] ; Patrick,Turko ^[1] ; Adel,Benlahrech ^[4] ; Jane,Harper ^[4] ; Anna,Broomfield ^[4] ; Antonio,Camera ^[4] ; Marianna,Ambrosio ^[3] ; Veronika,Haunerdinger ^[1] ; Phil F,Cheng ^[1] ; Egle,Ramelyte ^[1] ; James,Pham ^[5] ; Stefanie,Kreutmair ^[6] ; Burkhard,Becher ^[7] ; Mitchell P,Levesque ^[1] ; Reinhard,Dummer ^[1] ; Barbara,Meier-Schiesser ^[1]

作者单位： Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.;Medical Faculty, University of Zurich, Zurich, Switzerland. ^[1] Functional Genomics Center Zurich, University of Zurich and Eidgenössische Technische Hochschule (ETH) Zurich, Zurich, Switzerland. ^[2] Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. ^[3] Immunocore Ltd., Abingdon-on-Thames, United Kingdom. ^[4] Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.;School of Clinical Medicine, University of New South Wales Medicine and Health, Sydney, New South Wales, Australia. ^[5] Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.;Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. ^[6] Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. ^[7]

关键词 Cancer immunotherapy Dermatology Melanoma Oncology Skin